Oligoclonal expansion of TCR Vδ T cells may be a potential immune biomarker for clinical outcome of acute myeloid leukemia

BACKGROUND: Recent data have shown that γδ T cells can act as mediators for immune defense against tumors. Our previous study has demonstrated that persisting clonally expanded TRDV4 T cells might be relatively beneficial for the outcome of patients with T cell acute lymphoblastic leukemia after hem...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Hematol Oncol
Auteurs principaux: Jin, Zhenyi, Luo, Qiang, Lu, Shuai, Wang, Xinyu, He, Zifan, Lai, Jing, Chen, Shaohua, Yang, Lijian, Wu, Xiuli, Li, Yangqiu
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2016
Sujets:
Rapid Communication
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5116135/
https://ncbi.nlm.nih.gov/pubmed/27863523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-016-0353-3
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires